LawrenceRiceMD

PubMed

• Heparin-induced thrombocytopenia with very high antibody titer is associated with slower platelet recovery and higher risk of thrombosis.
  Akash Mukherjee, Cesar Gentille, Asmita Patel, Joe Ensor, Lawrence Rice
  International Journal of Hematology. 2024-09-01
• Interpreting coagulation mixing study results in the era of direct oral anticoagulants.
  Moon Joo Kim, Eric Salazar, Bonnie Philips, Lawrence Rice, Brian Castillo
  Blood Coagulation & Fibrinolysis. 2024-01-01
• Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry.
  Ethan A Burns, Justin J Wilson, Sunil Mathur, Ryan Kieser, Zimu Gong
  Annals of Hematology. 2023-10-01

Journal Articles

• Heparin PF4 antibody testing and treatment of heparin-induced thrombocytopenia in the intensive care unit  
  Wanat M, Fitousis K, Hall J, Rice L, Clin Appl Thrombos & Thrombolys, 1/1/2013
• Treatment of heparin-induced thrombocytopenia with direct thrombin inhibitors: trials results and implications  
  Jung M, Rice L, Clin Invest, 1/1/2013
• Orthotopic heart transplant facilitated autologous hematopoietic stem cell transplantation in light-chain amyloidosis  
  Kamble RT, Carrum G, Rice L, McCarthy J, Baker KR, Ramos CA, Adrogue H, Estep JD, Biol Blood Marrow Transpl, 1/1/2012
• The amyloidoses: Clinical Features, Diagnosis, and Treatment  
  Baker KR, Rice L, Methodist Debakey Cardiovasc J, 1/1/2012
• Amyloidosis: Changing Outlook and Expectations  
  Rice L, Baker KR, Methodist Debakey Cardiovasc J, 1/1/2012
• A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: the Pre...  
  Boyce SW, Bandyk DF, Bartholomew JR, Frame J, Rice L, Amer J Ther, 1/1/2011
• Unusual Autoimmune Non-Hematologic Complications in Chronic Lymphocytic Leukemia  
  Jung M, Rice L, Clinical Lymphoma, Myeloma & Leukemia, 1/1/2011
• Surgical Abdomen in a Patient with Chronic Lymphocytic Leukemia: A Case of Acquired Angioedema  
  Jung M, Rice L, J Gastrointest Surg, 1/1/2011
• Heparin-induced thrombocytopenia in the Cardiac Patient: Ten Points to Help the Physician  
  Rice L, Methodist Debakey Cardiovasc J, 1/1/2011
• Romiplostim: therapeutic value in chronic immune thrombocytopenic purpura  
  Tanaka MF, Rice L, Clinical Medicine Insights: Therapeutics, 1/1/2010
• Rationale and Design of the PREVENT-HIT Study: A Randomized, Open-Label, Pilot Study to Compare Desirudin and Argatroban in Patients With Suspected Heparin-Induced Thr...  
  Frame J, Rice L, Bartholomew JR, Whelton A, Clinical Therapeutics, 1/1/2010
• The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion  
  Cuker A, Arepally G, Crowther MA, Rice L, Datko F, Hook K, Propert KJ, Kuter DJ, Ortel TL, Konkle BA, Cines DB, J Thromb Hemost, 1/1/2010
• Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezimib is further potentiated by P38 MAPK inhibition  
  Wen J, Feng Y, Huang W, Chen H, Liao B, Rice L, Preti HA, Kamble RT, Zu Y, Ballon DJ, Chang CC, Leuk Res, 1/1/2010
• Evaluation and management of suspected heparin-induced thrombocytopenia in hospitalized patients  
  Crespo CM, Oliveira GBF, Honeycutt EF, Becker RC, Berger PB, Moliterno DJ, Anstrom KJ, Abrams CS, Kleiman NS, Moll S, Rice L, Rodgers JE, Steinhubl SR, Tapson VF, Gran..., Am Heart J, 1/1/2009
• Successful treatment of cyclic thrombocytopenia with thrombopoietin-mimetic agents: A report of two patients  
  Bose P, Hussein KK, Terrell DR, Berger D, Rice L, George JN, Am J Hematol, 1/1/2009
• Treatment of immune thrombocytopenic purpura: focus on eltrombopag  
  Rice L, Biologics: Targets & Therapy, 1/1/2009
• Severe iron overload associated with a novel aminolevulinate synthase mutation and hepatitis C  
  Lee P, Rice L, McCarthy JJ, Beutler E, Blood Cell Mol Dis, 1/1/2009
• Health-related quality of life improvements for patients with chronic immune thrombocytopenic purpura receiving romiplostim: results from two randomized, placebo contr...  
  George JN, Mathias S, Cuevas FJ, Go RS, Henry DH, Lyons R, Redner RL, Rice L, Schipperus MR, Brit J Haematol, 1/1/2009
• Changes of red blood cell surface markers in a blood-doping model of neocytolysis  
  Chang CC, Chen Y, Modi K, Awar OG, Alfrey CP, Rice L, J Investig Med, 1/1/2009
• Mast cell burden and reticulin fibrosis in the myeloproliferative neoplasms: a computer-assisted image analysis study  
  Ahmed A, Powers MP, Youker KA, Dunphy CH, Ewton A, Rice L, Zu Y, Chang CC, Pathol Research Pract, 1/1/2009
• ICD-9 Code for Heparin-induced thrombocytopenia: A needed and welcome change  
  Rice L, Physicians’ Weekly, 1/1/2008
• p38 mitogen activated protein kinase has different degrees of activation in myeloproliferative disorders and myelodysplastic syndromes  
  Shahjahan M, Dunphy CH, Ewton A, Zu Y, Monzon F, Rice L, Chang CC, Am J Clin Pathol, 1/1/2008
• Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy  
  Oliveira GBF, Crespo CM, Becker RC, Honeycutt EF, Abrams CS, Anstrom KJ, Berger PB, Davidson-Ray LD, Eisenstein EL, Kleiman NS, Moliterno DJ, Moll S, Rice L, Rodgers J..., Arch Int Med, 1/1/2008
• P38 MAPK inhibition enhancing ATO-induced cytotoxicity against multiple myeloma cells  
  Wen J, Cheng H, Rice L, Liu S, Mo A, Huang J, Zu Y, Ballon DJ, Chang CC, Brit J Haematol, 1/1/2008
• Argatroban therapy for heparin-induced thrombocytopenia  
  Rice L, Hursting MJ, Expert Rev in Clin Pharmacol, 1/1/2008
• Join now to see all

Books/Book Chapters

• Clinical Decision Support: Hematology. 
  Chapter: Heparin-Induced Thrombocytopenia. 
  Rice LEditors: Benz E, Berliner N, Brodsky R, Moake J.Decision Support in Medicine, Wilmington DE2013
• Protocolos en Cuidados Criticos 
  Chapter: Heparin-induced thrombocytopenia in the ICU. 
  Rice L, Baker KREditors: Rodriguez-Villar S.Marban Libros SL, Madrid, SpainEdition 2nd,2013
• Hematology: Basic Principles and Practice 
  Chapter: Neutrophilia, Neutropenia, Monocytosis and Monocytopenia. 
  Rice L, Jung MEditors: Hoffman R, et al.Elsevier, Philadelphia, PAEdition 6th,2012
• Heparin-induced thrombocytopenia. 
  Chapter: Argatroban therapy in heparin-induced thrombocytopenia. 
  Page 356 - 387Rice L, Beiderlein M, Hursting MEditors: Warkentin TE, Greinacher A.Informa, Colchester, United KingdomEdition 5th,2012
• Heparin-induced thrombocytopenia. 
  Chapter: A clinician’s perspective on heparin-induced thrombocytopenia: Paradoxes, myths and continuing challenges. 
  Page 608 - 617Rice LEditors: Warkentin TE, Greinacher A.Informa, Colchester, United KingdomEdition 5th,2012
• Protocolos en Cuidados Criticos. 
  Chapter: Heparin-induced thrombocytopenia in the ICU. 
  Page 889 - 894Rice L, Baker KREditors: Rodriguez-Villar S.Marban Libros SL, Madrid, Spain2011
• Conn’s Current Therapy 2009 
  Chapter: Non-Hodgkins Lymphomas. 
  Rice L, Popat UEditors: Rakel RE, Bope ET.WB Saunders, Philadelphia, PA2009
• Advances in the management of venous thromboembolic disorders associated with cancer and the antiphospholipid syndrome (a CME monograph based on a satellite symposium of the Amer Soc Hematology 48th annual meeting, 2006). 
  Chapter: Case study: Difficulties in differentiating hemostatic abnormalities in patients with cancer or APS. 
  Rice LEditors: Kelton JG.Global-Edge2008
• Conn’s Current Therapy 2008. 
  Chapter: Non-Hodgkins Lymphomas. 
  Page 458 - 461Rice L, Popat UEditors: Rakel RE, Bope ET.WB Saunders, Philadelphia, PA2008
• Heparin-induced thrombocytopenia. 
  Chapter: A clinician’s perspective on heparin-induced thrombocytopenia: Paradoxes, myths and realities. 
  Page 519 - 527Rice LEditors: Warkentin TE, Greinacher A.Marcel Dekker, New York, NYEdition 4th,2007
• Symposium Proceedings (Society for Vascular Surgery): Addressing key issues of heparin-induced thrombocytopenia (HIT) and venous thromboembolism (VTE) for vascular surgeons. 
  Chapter: What are the treatment options for heparin-induced thrombocytopenia (HIT) and venous thromboembolism (VTE) in the surgical care setting? 
  Page 18 - 23Rice LEditors: Bartholomew J, Kashyap VS, Rice L.Lumina, Tampa, FL2005
• Management and Prevention of Venous Thromboembolism in the Emergency Department: Adverse Effects of Heparin Therapy and New Anticoagulant Options. 
  Levine RL, Rice LInteractive Network for Continuing Education, Cranbury, NJ2005
• Conn’s Current Therapy 2005. 
  Chapter: Non-Hodgkins Lymphomas. 
  Page 521 - 525Rice L, Popat UEditors: Rakel RE, Bope ET.WB Saunders, Philadelphia, PA2005
• Oxygen Transport Enhancing Agents and Methods. 
  Chapter: Neocytolysis: implications to blood-doping. 
  Page 23 - 27Rice L, Alfrey CPEditors: Bowers L, Symanski E.US Anti-Doping Agency, Colorado Springs, CO2004
• ACP-ASIM Physicians’ Information and Education Resource 
  Chapter: Hemolytic Anemia. 
  Rice L, Popat UEditors: Goldmann D.2004
• Improving Patient Care: HIT and PCI. 
  Chapter: HIT Happens. 
  Rice LInteractive Network for Continuing Education, Cranbury, NJ2003
• Nutrition in Spaceflight and Weightlessness Models 
  Chapter: Iron metabolism and the changes in red blood cell metabolism. 
  Page 203 - 210Alfrey CP, Rice L, Smith, SMEditors: Lane H, Schoeller DA.CRC Press LLC, Boca Raton, FL2000
• Conn’s Current Therapy 1998. 
  Chapter: Hemochromatosis. 
  Page 393 - 396Rice LEditors: RE Rakel.W. B. Saunders, Philadelphia, PA1998
• Diagnostic challenges: Emerging recombinant cardiovascular therapeutics, Number 4. 
  Rice LMedical Age Publishing, Norwalk, CT1998
• Thrombosis, Anticoagulants and Antiplatelet Agents in Clinical Practice. 
  Chapter: Therapy of thromboembolic disease: The heparin thrombocytopenia/thrombosis syndrome. 
  Page 31 - 36Rice L, Huffman DM, Waddell CC, Luper WE, Udden MM, Levine MLPark Row Publishers, New York, NY1988
• Ferritins and Isoferritins as Biochemical Markers. 
  Chapter: Lymphocyte surface ferritin in malignant and inflammatory diseases. 
  Page 181 - 184Steinhoff G, van der Huel C, van Eijk HG, Rice L, Alfrey CPEditors: A Albertini, P Arosio, E Chiancone and J Drysdale.Elsevier Science Publishers, Amsterdam, New York, Oxford1984
• Hodgkin's and Non-Hodgkin's Lymphoma 
  Chapter: Impact of Hodgkin's Disease upon the immune system. 
  Page 26 - 37Twomey JJ, Rice LEditors: Coltman CA Jr., Golomb HA.Grune & Stratton, New York, NY1980
• Join now to see all

Abstracts/Posters

• Changes in platelet count after Heart Mate II insertion: implications for rational use of anti-platelet factor IV antibodies.
  Alvarez P, Kassi M, Cordero-Reyes AM, Uribe C, De Hoyos P, Bhimaraj A, Trachtenberg BH, Ashrith G, Torre-Amione G, Rice L, Estep JD, J Heart Lung Transpl, 1/1/2014
• Acquired and hereditary hypercoagulable states in patients with continuous flow left ventricular assist devices: prevalence and thrombotic complications.
  Alvarez P, Cordero-Reyes AM, Kassi M, Uribe C, DeHoyos P, Bhimaraj A, Trachtenberg BH, Ashrith G, Rice L, Torre-Amione G, Estep JD, J Cardiac Fail, 1/1/2014
• Neighborhood Death Rate: A Big-Data Based Health Informatics Pipeline Helps Identify Factors Impacting Clinical Outcomes and Cost Effectiveness in Acute Myeloid Leukem...
  Yin Z, Konde AS, Puppala M, Srivastava P, Wong S, Rice L, Iyer SP, Blood, 1/1/2014
• A Retrospective Review of Data from Houston Methodist Shows Increased Serum Ferritin Levels Directly Linked to Increase in Infections and Increased Mortality in AML Pa...
  Puppala M, Konde AS, Yin Z, Srivastava P, Baker KR, Wong ST, Rice L, Iyer SP, Blood, 1/1/2014
• Elevated Serum Ferritin Is a Significant Predictive Marker for Increase in Infection and Increased Mortality in Patients with Myelodysplastic Syndrome.
  Konde AS, Puppala M, Srivastava P, Wong ST, Baker KR, Rice L, Iyer SP, Blood, 1/1/2014
• A Review of MDS in Patients with Solid Organ Transplant Reveals a Higher Incidence but Not Necessarily Higher Mortality.
  Patel A, Konde AS, Puppala M, Wong ST, Srivastava P, Baker KR, Pingali SR, Rice L, Iyer SP, Blood, 1/1/2014
• A mystery case of severe recurrent neutropenia.
  Gadhia RR, Rice L, Amer Coll Physicians Regional Meeting, Houston, TX, 1/23/2013
• Evans’ Syndrome.
  McClean E, Cox J, Rice L, Zagloul H, National Pharmacy Meeting, 1/1/2013
• Hyperhemolytic Transfusion Reactions in Non-Sickle Cell Anemia Patients.
  Ahn I, Rice L, Blood, 1/1/2012
• Long-term treatment of Philadelphia chromosome negative myeloproliferative disorders with combination of hydroxyurea and anagrelide.
  Ahn I, Natelson EA, Rice L, Clinical Lymphoma, Myeloma & Leukemia Annual Meeting, Houston, TX, 1/1/2012
• Cells eating cells: Hepatosplenic T cell lymphoma mimicking hemophagocytic lymphohistiocytosis.
  Ahn IE, Rice L, Amer Coll Phys South Texas Regional Meeting, Houston, TX, 1/1/2012
• Ordering of heparin-PF4 antibody tests and treatment of heparin induced thrombocytopenia in the intensive care unit.
  Wanat MA, Fitousis K, Hall J, Rice L, J Thromb Haemostas, 1/1/2011
• Risks of IVC filters in the setting of heparin-induced thrombocytopenia.
  Jung M, McCarthy JJ, Baker KR, Rice L, J Thromb Haemostas, 1/1/2011
• Clinical characteristics of rituximab-induced late onset neutropenia.
  Yilmaz E, Mahani MG, Bilen MA, Baker KR, Rice L, Blood, 1/1/2011
• Orthotopic heart transplant facilitated autologous hematopoietic stem cell transplantation in light-chain amyloidosis.
  Kamble RT, Carrum G, Rice L, McCarthy J, Baker KR, Ramos CA, Adrogue H, Estep JD, Blood, 1/1/2011
• Safety of IVC filters with heparin-induced thrombocytopenia: A retrospective study.
  Jung M, McCarthy JJ, Baker KR, Rice L, Blood, 1/1/2011
• Combination hydroxyurea and anagrelide for essential thrombocythemia.
  Ahn I, Natelson EA, Rice L, Blood, 1/1/2011
• Outcomes of Transplantation in Primary Systemic Amyloidosis.
  Adrogue HE, Estep J, Kamble R, Carrum G, Rice L, Baker KR, Frenette C, Seetharamju H, Truong LD, Gaber LW, Gaber AO, Amer Soc Neph, 1/1/2011
• PREVENT-HIT: A randomized, comparative trial of desirudin vs. argatroban in suspected HIT.
  Boyce SW, Bandyk DF, Rice L, Amer Coll Clin Pharmacists, Austin, TX, 1/1/2010
• The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion.
  Cuker A, Arepally G, Crowther MA, Rice L, Datko F, Hook K, Propert KJ, Kuter DJ, Ortel TL, Konkle BA, Cines DB, Blood, 1/1/2010
• Construction and validation of a clinical scoring model for heparin-induced thrombocytopenia based on expert opinion.
  Cuker A, Arepally G, Crowther MA, Rice L, Datko F, Hook K, Propert KJ, Kuter DJ, Ortel TL, Konkle BA, Cines DB, Annual Scientific Symposium of the Hemophilia & Thrombosis Research Society and North American Specialized Coagulation Laboratory Association, 1/1/2010
• PREVENT-HIT: A randomized, comparative trial of desirudin vs. argatroban in suspected HIT.
  Boyce SW, Bandyk DF, Rice L, Annual Scientific Symposium of the Hemophilia & Thrombosis Research Society and North American Specialized Coagulation Laboratory Association, 1/1/2010
• Characterizing heparin-induced thrombocytopenia diagnosis and treatment in the intensive care unit.
  Wanat MA, Fitousis K, Hall J, Rice L, UHC/Amer Soc Health System Pharmacists, Anaheim, CA, 1/1/2010
• Impact of pharmacist managed heparin-induced thrombocytopenia dosing protocols.
  Tebbe SR, Nguyen PH, Putney DR, Rice L, Amer Coll Clin Pharmacists, Austin, TX, 1/1/2010
• Myasthenia Gravis: An unusual complication of CLL?
  Jung M, Harati Y, Rice L, ACP Regional Meeting, Houston, TX, 1/1/2010
• Join now to see all

Lectures

• Immunosuppressive therapy of Aplastic anemia. 
  1/21/2015
• Immune Thrombocytopenia 
  Houston, TX - 1/18/2014
• Thrombocytopenic Disorders 
  Omni Hotel, Houston, TX - 1/4/2014
• Autoimmune Complications of Lympho-Proliferative Disorders. 
  San Juan, Puerto Rico - 1/26/2013
• Hematologic Neurology 
  Houston Methodist Hospital - 1/1/2013
• Thrombotic Catastrophes. 
  Ben Taub Hospital - 1/28/2012
• Hematologic Emergencies 
  Houston, TX - 1/15/2012
• Thrombotic Catastrophes and DIC 
  1/14/2012
• Everything you wanted to know about Paroxysmal Nocturnal Hemoglobinuria. 
  Houston, TX - 1/10/2012
• Thrombocytopenias. 
  Methodist Hospital - 1/5/2012
• Acquired Coagulation Disorders. 
  Methodist Hospital - 1/1/2012
• CPC: A Case of Splenomegaly and Ureteral Obstruction (IgG4 Sclerosing Plasma Cell Disorder). Pathology Discussant 
  Methodist Hospital - 1/1/2011
• Paroxysmal Nocturnal Hemoglobinuria: Pathophysiology and Clinical Features 
  San Antonio, TX - 1/1/2011
• Amyloidosis. 
  The Methodist Hospital/ Weill Cornell Medical College - 1/1/2011
• Exploring an Uncommon but Quintessential Disease in Hematology. 
  San Antonio, TX - 1/1/2011
• A Case of Paroxysmal Nocturnal Hemoglobinuria (Chief Discussant) 
  Baylor College of Medicine - 1/1/2011
• Paradoxes, Myths and Misconceptions about Heparin-Induced Thrombocytopenia. 
  Durham, NC - 1/1/2010
• Prophylaxis for Venous thrombosis. 
  San Jacinto Methodist Hospital, Baytown, TX - 1/1/2010
• Practice-Changing Highlights from San Francisco 2008 (ASH): Hematology Treatment Updates 
  Orlando, FL - 1/1/2009
• Sideroblastic and Megaloblastic Anemias 
  1/1/2009
• Pardon the Iron: Update on iron overload in sickle cell anemia, MDS, Thalassemia. 
  New York City, NY - 1/1/2009
• Hemolytic Anemias 
  1/1/2009
• CPC: Acquired Coagulation Disorders 
  The Methodist Hospital, Houston, TX - 1/1/2009
• Disorders of Irom Metabolism 
  1/1/2009
• Acquired Coagulation Disorders 
  1/1/2009
• Join now to see all

Other

• Management of HIT: Case-Based Studies. National Webinar 
  Rice L
  https://francefoundation.webex.com/francefoundation/
  1/1/2009
• Heparin-induced thrombocytopenia: accurate diagnosis and timely management. (Clinical curriculum enduring primer/CME). 
  Bauer KA, Levy JH, Rice L, The France Foundation
  http://www.HITeducation.com
  1/1/2008
• Raising awareness on HIT. CME Interactive case study. 
  Rice L
  http://www.HITeducation.com
  1/1/2008
• Heparin-induced thrombocytopenia—Diagnosis and treatment. American School of Oncology Email Case Series 
  Rice L
  http://www.nocr.com
  1/15/2005
• Join now to see all